These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 20345333)

  • 1. Pharmacotherapy for inherited colorectal cancer.
    Lynch PM
    Expert Opin Pharmacother; 2010 May; 11(7):1101-8. PubMed ID: 20345333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of colorectal cancer in high-risk populations: the increasing role for endoscopy and chemoprevention in FAP and HNPCC.
    Lynch PM
    Digestion; 2007; 76(1):68-76. PubMed ID: 17947820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Colorectal cancer chemoprevention].
    Starzyńka T; Wasilewicz MP
    Pol Merkur Lekarski; 2007 Jul; 23(133):70-3. PubMed ID: 18051834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cohorts with familial disposition for colon cancers in chemoprevention trials.
    Burt RW
    J Cell Biochem Suppl; 1996; 25():131-5. PubMed ID: 9027609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sporadic and hereditary colorectal cancer. Pathogenetically different with different therapeutic indications].
    Weitz J; Knaebel HP; Büchler MW
    Chirurg; 2003 Aug; 74(8):717-25. PubMed ID: 12928792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary colorectal cancer syndromes.
    Strate LL; Syngal S
    Cancer Causes Control; 2005 Apr; 16(3):201-13. PubMed ID: 15947872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention with special reference to inherited colorectal cancer.
    Lynch PM
    Fam Cancer; 2008; 7(1):59-64. PubMed ID: 17680350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of colorectal cancer by endoscopic examinations].
    Porschen R; Strohmeyer G
    Z Gastroenterol; 1992 Nov; 30(11):823-8. PubMed ID: 1335193
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will gene testing cut risk of familial colorectal cancer?
    Lucassen A; Houlston R
    Practitioner; 1998 Apr; 242(1585):306-10, 314. PubMed ID: 10492991
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemoprevention of colorectal cancer].
    Herszényi L; Juhász M; Prónai L; Tulassay Z
    Orv Hetil; 2004 Mar; 145(12):603-10. PubMed ID: 15119114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic aspects of colorectal cancer].
    Abramowicz M
    Rev Med Brux; 2001 Sep; 22(4):A199-202. PubMed ID: 11680173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of patients with a positive family history of colorectal cancer.
    Burt RW
    Gastrointest Endosc Clin N Am; 1997 Jan; 7(1):65-79. PubMed ID: 8995113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of colorectal cancer.
    Winawer SJ
    Surg Oncol Clin N Am; 2005 Oct; 14(4):699-722. PubMed ID: 16226687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can we identify the high-risk patients to be screened? A genetic approach.
    Gammon A; Kohlmann W; Burt R
    Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoprevention in hereditary colorectal cancer syndromes.
    Hawk E; Lubet R; Limburg P
    Cancer; 1999 Dec; 86(11 Suppl):2551-63. PubMed ID: 10630181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing strategies for intervention/prevention trials of individuals at risk of hereditary colon cancer.
    Blackburn GL; Giardiello FM
    J Natl Cancer Inst Monogr; 1995; (17):107-10. PubMed ID: 8573441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early detection of colorectal carcinoma].
    Caspari R; Mezger J; Sauerbruch T
    Med Klin (Munich); 1996 May; 91(5):321; author reply 321-2. PubMed ID: 8709913
    [No Abstract]   [Full Text] [Related]  

  • 20. Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients.
    Koornstra JJ; Rijcken FE; Oldenhuis CN; Zwart N; van der Sluis T; Hollema H; deVries EG; Keller JJ; Offerhaus JA; Giardiello FM; Kleibeuker JH
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1608-12. PubMed ID: 16030090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.